Skip to content

Clinical trials

Phase 2 Liver Cirrhosis, Biliary trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis, Biliary Phase: Phase 2 Country / region: United Kingdom Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20121
20131
20141
20153
20162
20174
20191
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated5
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences3
Intercept Pharmaceuticals3
Mirum Pharmaceuticals, Inc.3
GlaxoSmithKline2
Calliditas Therapeutics AB1
Calliditas Therapeutics Suisse SA1
Enanta Pharmaceuticals, Inc1
Escient Pharmaceuticals, Inc1
Genfit1
Light Chain Bioscience - Novimmune SA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis, Biliary19
Pruritus4
Cholangitis1
Cholangitis, Sclerosing1
Cholestasis1
Cholestasis, Intrahepatic1
Digestive System Diseases1
Fatigue1
Fibrosis1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.